Kasey Bamel, NP
Articles
The Role of Molecular Testing in Treatment Decisions for NSCLC
Todd Bauer, MD;Sandip Patel, MD;Jonathan Riess, MD, MS ;Mary Grizzard, MSN, FNP ;Kasey Bamel, NP ;Cindy Ludovico, NP
December 23rd 2024This video segment explores the critical role of biomarker testing in identifying patients with ALK-positive NSCLC, discussing the clinical characteristics that guide the use of ALK inhibitors and addressing challenges in implementing comprehensive molecular testing in community settings.
Sarah’s Journey With ALK+ Metastatic NSCLC
Todd Bauer, MD;Sandip Patel, MD;Jonathan Riess, MD, MS ;Mary Grizzard, MSN, FNP ;Kasey Bamel, NP ;Cindy Ludovico, NP
December 23rd 2024A panel of experts review a case of a 55-year-old mom and high school teacher who received lorlatinib for ALK+ NSCLC with brain metastases.
Latest Updated Articles
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: May 1st 2015 | Updated: December 25th 2024
Neutropenia and Abdominal Pain in a 30-Year-Old Patient
Published: March 1st 2018 | Updated: December 25th 2024
45-Year-Old Female With Gross Hematuria Post Partial Nephrectomy
